Retinoblastoma MRI

Revision as of 20:13, 27 August 2015 by Jyostna Chouturi (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Retinoblastoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Retinoblastoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Retinoblastoma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Retinoblastoma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Retinoblastoma MRI

CDC on Retinoblastoma MRI

Retinoblastoma MRI in the news

Blogs on Retinoblastoma MRI

Directions to Hospitals Treating Retinoblastoma

Risk calculators and risk factors for Retinoblastoma MRI

MRI

High-resolution contrast enhanced MRI is the diagnostic technique of choice and should be used whenever possible to answer the key clinical questions. It has been proved to be the most sensitive technique for evaluating retinoblastoma[1] especially regarding tumor infiltration of the optic nerve, extraocular extension and intracranial disease. The 3D-multiplanar capability provide detailed examination of tumors and retrobulbar and intracranial structures. The tumor appears as heterogenously enhancing soft tissue mass with various degrees of calcification.[2] Lesions are typically hyperintense to vitreous on T1-weighted sequences and hypointense to vitreous on T2-weighted sequences.[3]

References

  1. de Graaf P, Göricke S, Rodjan F, Galluzzi P, Maeder P, Castelijns JA, Brisse HJ (2012). "Guidelines for imaging retinoblastoma: imaging principles and MRI standardization". Pediatric Radiology. 42 (1): 2–14. doi:10.1007/s00247-011-2201-5. PMC 3256324. PMID 21850471. Retrieved 2012-05-29. Unknown parameter |month= ignored (help)
  2. Kaste SC, Jenkins JJ, Pratt CB, Langston JW, Haik BG (2000). "Retinoblastoma: sonographic findings with pathologic correlation in pediatric patients". AJR. American Journal of Roentgenology. 175 (2): 495–501. PMID 10915702. Retrieved 2012-05-29. Unknown parameter |month= ignored (help)
  3. Kaufman LM, Mafee MF, Song CD (1998). "Retinoblastoma and simulating lesions. Role of CT, MR imaging and use of Gd-DTPA contrast enhancement". Radiologic Clinics of North America. 36 (6): 1101–17. PMID 9884691. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)

See also


Template:Nervous tissue tumors


Template:WikiDoc Sources